ストックスクリーナーアプリを入手
25.47
1.27%
0.34
Moderna Inc (MRNA) 最新ニュース
Guggenheim Capital LLC Reduces Stock Position in Moderna, Inc. (NASDAQ:MRNA) - MarketBeat
Altshuler Shaham Ltd Boosts Stock Holdings in Moderna, Inc. (NASDAQ:MRNA) - MarketBeat
What to Expect From Moderna's Q1 2025 Earnings Report - Nasdaq
Scotia Capital Inc. Has $284,000 Holdings in Moderna, Inc. (NASDAQ:MRNA) - MarketBeat
Brokerages Set Moderna, Inc. (NASDAQ:MRNA) Target Price at $58.70 - MarketBeat
Bridgewater Associates LP Makes New Investment in Moderna, Inc. (NASDAQ:MRNA) - MarketBeat
Wolfe Research Adjusts Moderna Price Target to $20 From $25, Keeps Underperform Rating - marketscreener.com
What To Expect From Moderna's Q1 2025 Earnings Report - Barchart.com
Preventive Vaccines Market Forecast 2025-2032- Growth - openPR.com
Where Will Moderna Be in 5 Years? - Yahoo Finance
Advisory Services Network LLC Purchases 16,555 Shares of Moderna, Inc. (NASDAQ:MRNA) - MarketBeat
Q1 Earnings Forecast for Moderna Issued By Leerink Partnrs - MarketBeat
Lobbying Update: $60,000 of MODERNA INC. lobbying was just disclosed - Nasdaq
Moderna (NASDAQ:MRNA) Earns Market Perform Rating from William Blair - MarketBeat
Russell Investments Group Ltd. Increases Stock Position in Moderna, Inc. (NASDAQ:MRNA) - MarketBeat
Bank of Montreal Can Trims Stock Position in Moderna, Inc. (NASDAQ:MRNA) - MarketBeat
The Gutierrez Co. Sued Over Mold, Water Damage at Moderna Site — Boston Business Journal - Boston Real Estate Times
Moderna sues construction firm claiming leaks, mold at new drug plant - NBC Boston
Water leaks, mold plague Moderna's new manufacturing site, lawsuit claims - The Business Journals
Quinn Opportunity Partners LLC Purchases Shares of 16,500 Moderna, Inc. (NASDAQ:MRNA) - MarketBeat
Moderna (MRNA) Stock Drops Despite Market Gains: Important Facts to Note - Yahoo Finance
US Advisory Panel Votes To Expand Recommendation For Pfizer, GSK's RSV Vaccines For Older Adults Below 60 Years - Benzinga
Invesco Ltd. Acquires 979,858 Shares of Moderna, Inc. (NASDAQ:MRNA) - MarketBeat
Moderna Says New Drug Plant Riddled With Defects, Mold - Law360
Moderna, Inc. (NASDAQ:MRNA) Shares Sold by Legal & General Group Plc - MarketBeat
Moderna (MRNA) Leads Healthcare Short Interest in March - GuruFocus
Lansdowne Partners UK LLP Acquires New Holdings in Moderna, Inc. (NASDAQ:MRNA) - MarketBeat
Neuberger Berman Group LLC Reduces Holdings in Moderna, Inc. (NASDAQ:MRNA) - MarketBeat
Bloom Energy, Rogers, 3D Systems, Moderna, and EchoStar Stocks Trade Down, What You Need To Know - The Globe and Mail
Moderna permitted to start commercial mRNA vaccine manufacture in UK - The Pharma Letter
Leerink Partners Adjusts Moderna Price Target to $23 From $27, Maintains Underperform Rating - marketscreener.com
Moderna Co-Founder and MIT Legend Strengthens Decoy Therapeutics Drug Development Team - Stock Titan
MRNA Based Vaccines and Therapeutics Therapeutics Market Size - openPR.com
APG Asset Management N.V. Has $9.15 Million Stock Holdings in Moderna, Inc. (NASDAQ:MRNA) - MarketBeat
Renaissance Technologies LLC Purchases 700,458 Shares of Moderna, Inc. (NASDAQ:MRNA) - MarketBeat
FDA Special Assistant Høeg’s Vaccine Concerns On Display At ACIP - insights.citeline.com
Moderna, Inc. (NASDAQ:MRNA) Shares Sold by Shelton Capital Management - MarketBeat
Stocks Edge Up On Strong Bank Earnings, Netflix Soars, Dollar Rebounds: What's Driving Markets Tuesday? - Benzinga
Goldman Sachs Adjusts Moderna's Price Target to $35 From $49, Keeps Neutral Rating - MarketScreener
Redburn Atlantic Adjusts Moderna's Price Target to $52 From $55, Keeps Neutral Rating - MarketScreener
Morgan Stanley Issues Pessimistic Forecast for Moderna (NASDAQ:MRNA) Stock Price - MarketBeat
Aviva PLC Lowers Position in Moderna, Inc. (NASDAQ:MRNA) - MarketBeat
Resona Asset Management Co. Ltd. Buys Shares of 94,753 Moderna, Inc. (NASDAQ:MRNA) - MarketBeat
Fmr LLC Has $776.08 Million Stock Holdings in Moderna, Inc. (NASDAQ:MRNA) - MarketBeat
1.75%
2.22%
大文字化:
|
ボリューム (24 時間):